[Not Available].
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology and CIC-1421, 75013 Paris, France; Inserm, CIC-1421 and UMR ICAN 1166, 75013 Paris, France; Sorbonne universités, UPMC University Paris 06, Faculty of Medicine, Department of Pharmacology and UMR ICAN 1166, 75013 Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), France. Electronic address: christian.funck-brentano@aphp.fr.
Christian
C
Funck-Brentano
Faculty of Medicine Paris-Descartes, Department of Public Health, Inserm, CIC-1418, Paris, France.
Joël
J
Ménard
D002423:Cause of Death; D002986:Clinical Trials as Topic; D003497:Cyclic N-Oxides / Q000009:adverse effects*; D064368:Healthy Volunteers; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*
C000612073:BIA 10-2474; D003497:Cyclic N-Oxides; D011725:Pyridines